穀胱甘肽 Glutathione × 肝臟健康

結論:證據不足

Human evidence for ORAL glutathione for general liver health does not reach the threshold of any controlled-evidence grade.

U ⚫ U 未驗證 證據不足 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示
⚗️ 研究進行中:本主題證據仍在累積、尚無定論;部分介入屬試驗階段,未必已在台上市或可購得。

Human evidence for ORAL glutathione for general liver health does not reach the threshold of any controlled-evidence grade. The only positive signals come from small, open-label, single-arm, uncontrolled NAFLD pilots (a 2017 n=34 pilot and a 2025 literature review of 3 studies totaling 109 participants) showing an ALT trend that cannot be separated from the concurrent lifestyle intervention or natural disease course. The single double-blind RCT (2020, cirrhosis, n=61, oral glutathione 500 mg/day) found NO significant effect on oxidative stress or antioxidant capacity. Examine has no liver outcome entry for glutathione at all (L1 coverage gap), and no major institution endorses it: AASLD and AGA do not mention oral glutathione in NAFLD/MASLD guidance, and Mayo, Cleveland Clinic and Harvard publish no supplement recommendation. The precursor NAC has genuine evidence in acute liver failure, but that is a different intervention and route and must not be conflated. With no adequate controlled human evidence supporting efficacy, the honest grade is U.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.46
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
U · 證據不足
信心度
70%
證據方向大致一致
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.20
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.55
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.455
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
PMID: 40149620 2025 Other n = 109
結論:Across 3 studies (109 participants) oral glutathione showed consistent improvements in ALT and reductions in oxidative stress markers, but the authors stress that small sample sizes, inconsistent protocols and absence of RCTs limit generalizability; large-scale RCTs are needed before clinical recommendation.
🟠 品質有限 效應量:Qualitative ALT improvement only; no pooled effect size (not a meta-analysis)
前往 PubMed
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
PMID: 28789631 2017 RCT (open-label) n = 34
結論:In 29 completers ALT decreased significantly after 4 months of oral glutathione; triglycerides, non-esterified fatty acids and ferritin also fell, and controlled attenuation parameter improved in ALT responders. Authors explicitly state large-scale clinical trials are needed to verify efficacy.
🟠 品質有限 效應量:Significant ALT reduction; magnitude not controlled (no comparator arm)
前往 PubMed
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study
PMID: 32635181 2020 RCT (double-blind) n = 61
結論:Although reduced glutathione and related enzyme activity correlated with cirrhosis severity, oral glutathione and/or vitamin B-6 supplementation had NO significant effect on reducing oxidative stress or increasing antioxidant capacity over 12 weeks.
政府資助 效應量:Null — no significant between-group difference
前往 PubMed
N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies
PMID: 35371352 2022 統合分析
結論:N-acetylcysteine (the glutathione precursor) was associated with improved outcomes in non-acetaminophen acute liver failure; for acetaminophen-induced liver failure NAC has been standard of care since the 1970s. Note this concerns the precursor NAC and intravenous use, not oral glutathione for general liver health.
效應量:Improved transplant-free survival (precursor NAC, IV)
前往 PubMed

L4a US FDA
反對
FDA warns compounders not to use glutathione L-reduced powder distributed by Letco Medical to compound sterile injectable drugs for patients. The L-glutathione powder was labeled with 'Caution: Dietary Supplement' and should not have been used to compound sterile injectable drugs. 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
謹慎
由圓酵母(Torula yeast)發酵製成之食品原料穀胱甘肽,其每日食用限量為二百五十毫克,且應標示「對穀胱甘肽過敏者、孕婦、哺乳婦女及嬰幼兒應避免食用」之警語字樣。 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
中性
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群對穀胱甘肽的討論量大,但幾乎集中在「美白淡斑」(PTT BeautySalon、Dcard 美妝版),主流經驗偏向質疑或無共識(多人「無感+1」「完全沒效」,少數覺得淡斑有感)。針對「肝臟健康/護肝」的討論極少出自真實鄉民實測,多半出現在 vocus、嚴萃、痞客邦等業配型「護肝保健品推薦」清單文中,業配密度高。科普方/反業配者反覆強調口服穀胱甘肽會被胃酸與蛋白酶分解、生物利用度低於 1%,因此護肝功效存疑。整體屬 anecdotal,不構成研究證據。

💬社群實感

無共識(護肝面向幾乎無真實鄉民實測;現有討論集中於美白,且美白經驗分歧偏負面)

破解迷思 社群最常見的 4 個誤解
事實口服穀胱甘肽能直接『補進肝臟』護肝(錯誤:胜肽會被胃酸與蛋白酶分解,口服生物利用度低於 1%,多數研究不認為能被有效吸收)
事實把美白保健品當『護肝聖品』,認為熬夜應酬吃了就能降肝指數(缺乏人體護肝實證,多源自業配清單文)
事實劑量越高越補肝(身體無法一次吸收大量,水溶性成分多由腎臟與腸胃排出;衛福部上限 250mg/日)
事實穀胱甘肽是『缺什麼補什麼』的解毒劑(人體可自行合成,正常人並無 GSH 缺乏症需口服補充)
🩹 社群通報的副作用
  • 腸胃過敏不適(腹痛、腹瀉、噁心嘔吐)
  • 皮膚紅腫、發癢
  • 部分人反映吃了反而冒痘
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • NOW Foods(國外代購 500mg,社群常見比較對象)
  • 活沛多(NutriPlus)穀胱甘肽錠
  • BHK's
  • 你滋美得
  • VITABOX
  • 三得利/桂格(出現在護肝保健品推薦清單,多為美白以外的護肝定位)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

可以補充穀胱甘肽搭配維他命C,每日不超過250毫克長期補充,能夠增進肌膚的抵抗力

代表來源 ↗
L10b · TFDA 法定身份 官方認定

由圓酵母發酵製成之穀胱甘肽,其每日食用限量為二百五十毫克

來源 ↗

  • 戒酒或減少飲酒
  • 體重管理與代謝風險控制
  • 病毒性肝炎疫苗接種與篩檢
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v23 engine_version: v1.0 claim_id: CLM-COND-liver-health-INT-glutathione-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-liver-health-INT-glutathione-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "穀胱甘肽能改善肝臟健康",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "alternateName": "證據不足 (Insufficient evidence)"
  }
}